Diabetes, Obesity, and Cardiometabolic CARE
Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
Cohort study of 115,091 peopleType 2 diabetes
Stage 3 or worse chronic kidney disease
Papers on stage 3 or worse chronic kidney disease
1 paper1 new in 30 days